UB Paderborn / Katalog / Suche / in CDI

High Aldehyde Dehydrogenase Activity Identifies Tumor-Initiating and Metastasis-Initiating Cells in Human Prostate Cancer

Cancer research (Chicago, Ill.), 2010-06, Vol.70 (12), p.5163-5173

2010

Link zum Volltext

Verfügbarkeit prüfen

iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer

PloS one, 2012-02, Vol.7 (2), p.e30885-e30885

2012

Link zum Volltext

Verfügbarkeit prüfen

Parathyroid Hormone (PTH) Increases Skeletal Tumour Growth and Alters Tumour Distribution in an In Vivo Model of Breast Cancer

International journal of molecular sciences, 2018-09, Vol.19 (10), p.2920

2018

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the frequency of putative prostate cancer stem cells in primary and metastatic prostate cancer

The Prostate, 2010-06, Vol.70 (8), p.875-882

2010

Link zum Volltext

Verfügbarkeit prüfen

Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche

Nature communications, 2015-12, Vol.6 (1), p.8983-8983, Article 8983

2015

Link zum Volltext

Verfügbarkeit prüfen

Zoledronic Acid Has Differential Antitumor Activity in the Pre- and Postmenopausal Bone Microenvironment In Vivo

Clinical cancer research, 2014-06, Vol.20 (11), p.2922-2932

2014

Link zum Volltext

Verfügbarkeit prüfen

Prostate Cancer Cells Preferentially Home to Osteoblast‐rich Areas in the Early Stages of Bone Metastasis: Evidence From In Vivo Models

Journal of bone and mineral research, 2014-12, Vol.29 (12), p.2688-2696

2014

Link zum Volltext

Verfügbarkeit prüfen

Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bone

Endocrine-related cancer, 2014-10, Vol.21 (5), p.769-781

2014

Link zum Volltext

Verfügbarkeit prüfen

OPG‐Fc inhibits ovariectomy‐induced growth of disseminated breast cancer cells in bone

International journal of cancer, 2015-08, Vol.137 (4), p.968-977

2015

Link zum Volltext

Verfügbarkeit prüfen

Mitotic quiescence, but not unique “stemness,” marks the phenotype of bone metastasis‐initiating cells in prostate cancer

The FASEB journal, 2015-08, Vol.29 (8), p.3141-3150

2015

Link zum Volltext

Verfügbarkeit prüfen

Increased expression of putative cancer stem cell markers in primary prostate cancer is associated with progression of bone metastases

The Prostate, 2012-05, Vol.72 (7), p.713-720

2012

Link zum Volltext

Verfügbarkeit prüfen

Increased expression of putative cancer stem cell markers in the bone marrow of prostate cancer patients is associated with bone metastasis progression

The Prostate, 2013-12, Vol.73 (16), p.1738-1746

2013

Link zum Volltext

Verfügbarkeit prüfen

The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancer

Journal of experimental & clinical cancer research, 2015-10, Vol.34 (1), p.124-124, Article 124

2015

Link zum Volltext

Verfügbarkeit prüfen

Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells

Cancer research (Chicago, Ill.), 2002-03, Vol.62 (6), p.1619-1623

2002

Link zum Volltext

Verfügbarkeit prüfen

iTRAQ-Facilitated Proteomic Analysis of Human Prostate Cancer Cells Identifies Proteins Associated with Progression

Journal of proteome research, 2008-03, Vol.7 (3), p.897-907

2008

Link zum Volltext

Verfügbarkeit prüfen

Prostate cancer cells home to bone using a novel in vivo model: Modulation by the integrin antagonist GLPG0187

International journal of cancer, 2015-04, Vol.136 (7), p.1731-1740

2015

Link zum Volltext

Verfügbarkeit prüfen

The BMP antagonist Noggin is produced by osteoblasts in response to the presence of prostate cancer cells

Biotechnology and applied biochemistry, 2018-05, Vol.65 (3), p.407-418

2018

Link zum Volltext

Verfügbarkeit prüfen

Eight-plex iTRAQ analysis of variant metastatic human prostate cancer cells identifies candidate biomarkers of progression: An exploratory study

The Prostate, 2010-09, Vol.70 (12), p.1313-1332

2010

Link zum Volltext

Verfügbarkeit prüfen

Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo : a role in tumour cell survival?

Breast cancer research and treatment, 2005-08, Vol.92 (3), p.207-215

2005

Link zum Volltext

Verfügbarkeit prüfen

Human Bone Marrow Stromal Cells Protect Prostate Cancer Cells From TRAIL‐Induced Apoptosis

Journal of bone and mineral research, 2004-10, Vol.19 (10), p.1712-1721

2004

Link zum Volltext

Verfügbarkeit prüfen

Aetiology and pathogenesis of benign prostatic hyperplasia

Current opinion in urology, 2003-01, Vol.13 (1), p.7-10

Eaton, Colby L

2003

Link zum Volltext

Verfügbarkeit prüfen

Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer

The Prostate, 2004-05, Vol.59 (3), p.304-310

2004

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3481: Continuous load bearing exercise inhibits the development of prostate cancer bone metastasis

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.3481-3481

2020

Link zum Volltext

Verfügbarkeit prüfen

The antibody MAB8051 directed against osteoprotegerin detects carbonic anhydrase II: Implications for association studies with human cancers

International journal of cancer, 2007-11, Vol.121 (9), p.1958-1966

2007

Link zum Volltext

Verfügbarkeit prüfen

The Survival Effect of Prolactin on PC3 Prostate Cancer Cells

European urology, 2003-03, Vol.43 (3), p.301-308

2003

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

High Aldehyde Dehydrogenase Activity Identifies Tumor-Initiating and Metastasis-Initiating Cells in Human Prostate Cancer

iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer

Parathyroid Hormone (PTH) Increases Skeletal Tumour Growth and Alters Tumour Distribution in an In Vivo Model of Breast Cancer

Evaluation of the frequency of putative prostate cancer stem cells in primary and metastatic prostate cancer

Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche

Zoledronic Acid Has Differential Antitumor Activity in the Pre- and Postmenopausal Bone Microenvironment In Vivo

Prostate Cancer Cells Preferentially Home to Osteoblast‐rich Areas in the Early Stages of Bone Metastasis: Evidence From In Vivo Models

Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bone

OPG‐Fc inhibits ovariectomy‐induced growth of disseminated breast cancer cells in bone

Mitotic quiescence, but not unique “stemness,” marks the phenotype of bone metastasis‐initiating cells in prostate cancer

Increased expression of putative cancer stem cell markers in primary prostate cancer is associated with progression of bone metastases

Increased expression of putative cancer stem cell markers in the bone marrow of prostate cancer patients is associated with bone metastasis progression

The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancer

Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells

iTRAQ-Facilitated Proteomic Analysis of Human Prostate Cancer Cells Identifies Proteins Associated with Progression

Prostate cancer cells home to bone using a novel in vivo model: Modulation by the integrin antagonist GLPG0187

The BMP antagonist Noggin is produced by osteoblasts in response to the presence of prostate cancer cells

Eight-plex iTRAQ analysis of variant metastatic human prostate cancer cells identifies candidate biomarkers of progression: An exploratory study

Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo : a role in tumour cell survival?

Human Bone Marrow Stromal Cells Protect Prostate Cancer Cells From TRAIL‐Induced Apoptosis

Aetiology and pathogenesis of benign prostatic hyperplasia

Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer

Abstract 3481: Continuous load bearing exercise inhibits the development of prostate cancer bone metastasis

The antibody MAB8051 directed against osteoprotegerin detects carbonic anhydrase II: Implications for association studies with human cancers

The Survival Effect of Prolactin on PC3 Prostate Cancer Cells

Suchergebnisse filtern